Dr. Steven M. Wolf, MD

Dr. Wolf practices at Premier Healthcare, Inc. in New York, New York.

Dr. Wolf's NPI, 1487645693, was assigned on November 4, 2005. Dr. Wolf graduated from Albany Medical College in 1989. Dr. Wolf holds New York license 183592.

Dr. Wolf's primary practice is Premier Healthcare, Inc., at 227 E 41st St, New York, NY 10017 in New York County. The practice phone is (212) 273-6272.

Dr. Wolf's primary practice is Premier Healthcare, Inc. in New York, New York. Dr. Wolf is also affiliated with Westchester Medical Center. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Wolf to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolf practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Wolf's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Wolf is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Wolf is licensed in New York.

Dmand AI lists alzheimer's disease, encephalopathy, epilepsy, mobility impairment, muscle disease, neck pain and spine problems, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Dr. Wolf treats.

CMS data shows 602 Medicare services from Dr. Wolf across 8 procedure codes in 2024, for 247 Medicare patients. Medicare paid $75,455 for them. Every service was in an office.

CMS counts 247 Medicare patients who saw Dr. Wolf in 2024. The largest group is under 65, with 203 patients. 51% of them have high cholesterol, and 42% have adhd and conduct disorders. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wolf's median patient age at 21, with 41% women.

In 2024, Dr. Wolf wrote 3,693 Medicare Part D claims for 307 patients. 85% of them were for generic drugs. CMS names the drug for 3,392 of them, across 64 drugs with 11 or more claims each, at $1,083,396 in total drug cost. In 2023, CMS named 3,369 claims across 69 drugs.

Dr. Wolf accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wolf as offering telehealth.

Dmand AI links 74 papers to Dr. Wolf, published from 2005 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Drug Resistant Epilepsy, Epilepsy and Electroencephalography. Dr. Wolf has published most often in Neurorehabil Neural Repair. Dr. Wolf's most frequent co-authors are Saadi Ghatan, MD, Carrie R. Muh, MD, MS and Elissa G. Yozawitz, MD.

Dmand AI links Dr. Wolf to 6 clinical trials, 2 of them phase 3 studies. Conditions studied include Epilepsy, Brain Diseases and Seizures. Aquestive Therapeutics sponsors the most, 2.

CMS Open Payments shows 1,831 general payments to Dr. Wolf from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Eisai Inc. paid the most, $140,487. It also lists 85 research payments totaling $107,388 from 2019 to 2025.

Dmand AI lists 11 awards for Dr. Wolf, most recently Castle Connelly's Top Doctors in 2019.

Dr. Wolf graduated from Albany Medical College in 1989. Dr. Wolf is a member of AAN.

Dr. Wolf is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.